XML 46 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Segment Reporting Information By Segment
A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
MedSurg*
$
751

 
$
680

 
$
1,462

 
$
1,321

Rhythm and Neuro*
775

 
700

 
1,512

 
1,368

Cardiovascular
965

 
876

 
1,898

 
1,728

 
$
2,490

 
$
2,257

 
$
4,870

 
$
4,418

 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
 
 
MedSurg*
$
273

 
$
244

 
$
532

 
$
459

Rhythm and Neuro*
160

 
137

 
313

 
246

Cardiovascular
300

 
262

 
590

 
494

Operating income allocated to reportable segments
734

 
643

 
1,436

 
1,199

Corporate expenses, including hedging activities
(100
)
 
(56
)
 
(200
)
 
(115
)
Intangible asset impairment charges, acquisition-related, restructuring- and restructuring-related and litigation-related net credits (charges)
(95
)
 
(220
)
 
(149
)
 
(210
)
Amortization expense
(147
)
 
(142
)
 
(288
)
 
(285
)
Operating income (loss)
392

 
225

 
799

 
589

Other expense, net
(45
)
 
(134
)
 
(129
)
 
(193
)
Income (loss) before income taxes
$
347

 
$
91

 
$
670

 
$
396

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income as a Percentage of Segment Net Sales
 
 
 
 
 
 
MedSurg*
36.4
%
 
35.8
%
 
36.4
%
 
34.7
%
Rhythm and Neuro*
20.6
%
 
19.6
%
 
20.7
%
 
18.0
%
Cardiovascular
31.1
%
 
29.8
%
 
31.1
%
 
28.6
%